Home » Oxytrol Bladder Drug Patent Suit Settled by Watson, Barr
Oxytrol Bladder Drug Patent Suit Settled by Watson, Barr
Watson Laboratories has settled a patent infringement
lawsuit with Barr Laboratories over the overactive bladder drug Oxytrol. Watson has granted Barr a royalty-bearing license to the U.S. patents covering
Oxytrol (oxybutynin) as part of the agreement. Barr may start marketing its product April 26, 2015, or earlier under certain circumstances.
Generic Line
Generic Line
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May